Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)-Reference-Cited by-同舟云学术

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Published:2015-06 Issue:9985 Volume:385 Page:2363-2370
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Washam Jeffrey B,Stevens Susanna R,Lokhnygina Yuliya,Halperin Jonathan L,Breithardt Günter,Singer Daniel E,Mahaffey Kenneth W,Hankey Graeme J,Berkowitz Scott D,Nessel Christopher C,Fox Keith A A,Califf Robert M,Piccini Jonathan P,Patel Manesh R

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014

2. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study;Chugh;Circulation,2014

3. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics;Magnani;Circulation,2011

4. Rate control in the medical management of atrial fibrillation;Camm;Heart,2007

5. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur Heart J,2010

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digoxin initiation after an acute heart failure episode and its association with post-discharge outcomes: an international multicenter analysis;Internal and Emergency Medicine;2024-08-22

2. Digoxin and Risk of Ventricular Tachyarrhythmia and Death in ICD Recipients;JACC: Clinical Electrophysiology;2024-07

3. Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA–AF registry;Internal and Emergency Medicine;2024-05-23

4. The impact of sex on stroke care: From epidemiology to outcome;Journal of Stroke and Cerebrovascular Diseases;2024-05

5. An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease;Reviews in Cardiovascular Medicine;2024-04-11